Navigation Links
VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
Date:9/7/2007

SAN JOSE, Calif., Sept. 7 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced the resignation of Timothy A. Marcotte, Chief Financial Officer and Vice President, Finance & Administration, to be effective October 1, 2007, to pursue another business opportunity. VNUS has begun a search for a new chief financial officer.

VNUS President and Chief Executive Officer Brian E. Farley stated, "We want to thank Tim for his many contributions to VNUS since joining the company in April 2004."

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of symptomatic varicose veins. VNUS sells the VNUS Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Robots craft medical history
5. NBE to conduct test for medical students from abroad
6. Air pollution combined with greater medical needs
7. Indian Nationals with Foreign Medical Degrees can now practice in India
8. Children! Protecting them from medical mistakes
9. More information sought by patients on medical errors
10. SARS necessitates medical masks
11. Meditation Works Medically

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...e patient outcomes, research suggests , ,...ation drug therapy shows promise in treating patie...rs say. , The study from the Massachusetts Gene...rvival and tumor response in patients treated with...that has helped slow the growth of other cancers, ...
(Date:11/23/2009)... get sick, study finds , , MONDAY, Nov. ...netic variation appears to play a major role in sl.... , In fact, those with the variation appear ...mplications of the disease. , "We,re honing i...e a person more or less susceptible to HIV, in ter...
(Date:11/23/2009)...23/PRNewswire/--HealthLeaders-InterStudy,aleadingp...self-insuredmembercompaniesthatarepartofMilwaukee,...healthcare-costdecreaseof1.5percentperhealthplanme...formanceprovidernetwork.Accordingtothe MilwaukeeMa...mbercompaniessaved$44millioninhealthcarecostsovert...
(Date:11/23/2009)...re-FirstCall/-- ,, DearIsisSupportersandShareho...continuingsupportofIsis.Webelieveweareatoneofthemo...ofthebeginningofcreatingauniquecompanywithanoveldr...heissueshauntingthepharmaceuticalindustry. ,, O...agshipdrug,mipomersen.Mipomersencontinuestoperform...
(Date:11/23/2009)...erylCompanies,thenation,sleadingproviderofoutsourc...rnedrecognitionasoneofthetopoutsourcingfirmsinheal...demagazine.Berylwasrankedamongthepublication,stop2...,whichenabledittoclimbfromtwelfthplacein2007totent...tiveproducts,suchasitsnewestlaunchofpost-discharge...
Breaking Medicine News(10 mins):Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2
..., PhD, FNP Join Together to Raise Awareness of Com... , ANAHEIM, Calif., May 12 Fibromyalgia is often...who have it typically do not look sick. However, ...e U.S., affecting more than five million Americans...
...e.com, Recommended to Help Guide Important Convers...nosis , , NEW YORK, May 12 The multi-disciplina...ase Screening Discussion Group (ADSDG) is calling ...,s disease (AD) symptoms. The goal of the call-to-...
...nce, Biomarker Strategies and Pharma on Panel , ,...nc. (NYSE Amex: ILI ) announced today that CEO L...l discussion titled "Integrating Genetic Markers i...anta, GA. The panel discussion will be held Tuesd...
... Inc., the leading provider of pathway data minin...ion, the premiere visualization and analysis softw...a, today announced the integration of the MetaCore...tion will benefit," said Julie Bryant, VP of Busin...
...he rating agency,Standard & Poor,s has today c...eimer Group and continues to categorize the outloo...pharma & life science industry is therefore,as...urope,America and Asia. In the financial year 2008...
...emier medical and surgical equipment supplier, now...nt monitors that feature clinically-proven techno... , (Vocus) May 12, 2009 --...de the DRE ASM 6000 and DRE ASM 6000 Pro, sleek pa...
Other Medicine News:Health News:VIDEO from Medialink, the National Fibromyalgia Association and Pfizer: The Painful Truth about Fibromyalgia 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 3Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 4Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 5Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 2Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 3Health News:GeneGo and OmicSoft Announce Integration 2Health News:GeneGo and OmicSoft Announce Integration 3Health News:DRE Medical Equipment Releases New Multi-Function Patient Monitors 2
(Date:11/23/2009)...tCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBA...y( http://www.cordblood-america.com )focusedonbrin...nsurancepolicy,tofamiliesnationwideandinternationa...thCEOandco-founderMatthewSchisslerisnowavailable. ...2875811 . ,, Intheinterview,Mr.Schisslerupdates...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...tationofclinicaltrialdataonNGX426,theCompany,soral...gonist,atthe12thInternationalConferenceontheMechan...-21inSanFrancisco.TheresultsofthestudyledbyMarkWal...nterforPainMedicineoftheUniversityofCaliforniaatSa...
(Date:11/23/2009)...wire-FirstCall/--Oceanside Pharmaceuticals ,partof...todayannouncedthatithasnowlaunchedchlordiazepoxide...ic(AG)versionofLibrax®.Oceansidehasreceivedit...ibrax®genericmarket. ,, "Valeant,sOceansid...withitssuccessfullaunchanddistributionof5%fluorour...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 1Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 3 Evaluation of standard liver volume formula for Chinese adults 57348 1HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1
...n Evolve Student Journalism Award, PRINCETON, N.J...and the NSRC,s Campaign for Sexual Literacy are no...e Student Journalism Award.,The award will recogni...eporting on sexual health topics in their college ...U.S. can apply by submitting an article,published ...
...icals,Inc. (Amex: IMM ) announced that the presen...eeting will be posted on the Company,s website, ht..., About Immtech Pharmaceuticals, Inc., Immtech P...commercializing drugs to treat infectious diseases...ude new treatments for Pneumocystis pneumonia,(PCP...
Other Medicine Technology:Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 2Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 3Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 4Immtech Announces Posting of Annual Shareholders Meeting Presentation 2
Disposable Caps and Plugs
Bivona® Uncuffed Pediatric FlexTend™ Plus Standard Tracheostomy Tubes
Bivona® TTS™ Cuffed Pediatric Tracheostomy Tubes
Portex® Extra Length Pediatric Tracheostomy Tubes with 15 mm Connector
Medicine Products: